S7C.F STENOCARE DK-08

Healthcare Pharmaceuticals Frankfurt Exchange
0.0834 EUR
Close of Nov 12, 2026
0.0744 0.3460
Market cap
EUR 3.60M
P/E
-
P/B
3.40x
ROE
-26.6%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is S7C.F undervalued?

Graham number

The Graham number of STENOCARE DK-08 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

STENOCARE DK-08 fundamental analysis

No fundamental analysis for STENOCARE DK-08 yet.

STENOCARE DK-08 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About STENOCARE DK-08

Stenocare A/S cultivates, produces, imports, distributes, and sells prescription-based medical cannabis products to patients in Denmark and internationally. It offers medical cannabis oil products, including THC, THC/CBD, and CBD, as well as CBD100 oil products. The company was incorporated in 2017 and is based in Randers, Denmark.

Full company profile